Validation checklist for initial marketing authorisation applications - biologicals other than immunologicals (applicable to submissions under Regulation (EU) 2019/6)

June 20, 2022

JUNE 2022

EMA/278419/2022-Rev.1

This validation checklist is used by the Agency to validate initial marketing authorization applications for pharmaceuticals and applicants should use it as a means to review in advance of their submission that standard requirements are fulfilled.

Download the Checklist

Interested in learning more? Contact us today to find out how we can help not only with your EMA/FDA submissions, but all of your global regulatory needs.




EMA Europe

June 20, 2022

IRIS guide for applicants (How to create and submit scientific applications, for industry and individual applicants)

This guide has been produced to show applicants how to use the IRIS platform to prepare and submit an application and/or data for a scientific procedure (orphan designation application, scientific...

Read More
Medical Device Agency Alerts

June 20, 2022

FDA Grants Two Mobile Medical Applications to be Used with the Apple Watch

On Tuesday, September 11th, FDA granted two de novo classification requests for mobile medical applications to be used with the Apple Watch. ECG App The first app, referred to as the ECG app,...

Read More
Pharmacovigilance

June 20, 2022

EMA Vaccine Applications for COVID-19 Explained

Preventive vaccines are a special kind of medicinal product, as they are administered before a disease instead of during. You are probably familiar with preventive vaccines from your own or your...

Read More